293 related articles for article (PubMed ID: 29057449)
1. Efficacy and tolerability of mexiletine treatment in patients with recurrent ventricular tachyarrhythmias and implantable cardioverter-defibrillator shocks.
Sobiech M; Lewandowski M; Zając D; Maciąg A; Syska P; Ateńska-Pawłowska J; Kowalik I; Sterliński M; Szwed H; Pytkowski M
Kardiol Pol; 2017; 75(10):1027-1032. PubMed ID: 29057449
[TBL] [Abstract][Full Text] [Related]
2. Mexiletine as an adjunctive therapy to amiodarone reduces the frequency of ventricular tachyarrhythmia events in patients with an implantable defibrillator.
Gao D; Van Herendael H; Alshengeiti L; Dorian P; Mangat I; Korley V; Ahmad K; Golovchiner G; Aves T; Pinter A
J Cardiovasc Pharmacol; 2013 Aug; 62(2):199-204. PubMed ID: 23609328
[TBL] [Abstract][Full Text] [Related]
3. Mexiletine for ventricular arrhythmias in patients with chronic coronary syndrome: a cohort study.
Mugnai G; Paolini C; Cavedon S; Mecenero A; Perrone C; Bilato C
Acta Cardiol; 2022 May; 77(3):264-270. PubMed ID: 34006205
[TBL] [Abstract][Full Text] [Related]
4. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
[TBL] [Abstract][Full Text] [Related]
5. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
AbdelWahab A; Sapp J
Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
[TBL] [Abstract][Full Text] [Related]
6. Mexiletine for recurrent ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter defibrillator: an EHRA systematic review.
Farkowski MM; Karlinski M; Pytkowski M; de Asmundis C; Lewandowski M; Mugnai G; Conte G; Marijon E; Anic A; Boveda S; Providencia R
Europace; 2022 Oct; 24(9):1504-1511. PubMed ID: 35851797
[TBL] [Abstract][Full Text] [Related]
7. Use of mexiletine in therapy-refractory recurrent ventricular tachycardia storm.
Szonyi MD; Pap R; Vamos M
Herzschrittmacherther Elektrophysiol; 2023 Dec; 34(4):326-329. PubMed ID: 37917362
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy.
Haïssaguerre M; Sacher F; Nogami A; Komiya N; Bernard A; Probst V; Yli-Mayry S; Defaye P; Aizawa Y; Frank R; Mantovan R; Cappato R; Wolpert C; Leenhardt A; de Roy L; Heidbuchel H; Deisenhofer I; Arentz T; Pasquié JL; Weerasooriya R; Hocini M; Jais P; Derval N; Bordachar P; Clémenty J
J Am Coll Cardiol; 2009 Feb; 53(7):612-619. PubMed ID: 19215837
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268
[TBL] [Abstract][Full Text] [Related]
10. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
[TBL] [Abstract][Full Text] [Related]
12. Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
Bunch TJ; Mahapatra S; Murdock D; Molden J; Weiss JP; May HT; Bair TL; Mader KM; Crandall BG; Day JD; Osborn JS; Muhlestein JB; Lappe DL; Anderson JL
Pacing Clin Electrophysiol; 2011 Dec; 34(12):1600-6. PubMed ID: 21895727
[TBL] [Abstract][Full Text] [Related]
13. Oral procainamide as pharmacological treatment of recurrent and refractory ventricular tachyarrhythmias: A single-center experience.
Toniolo M; Muser D; Grilli G; Burelli M; Rebellato L; Daleffe E; Facchin D; Imazio M
Heart Rhythm O2; 2021 Dec; 2(6Part B):840-847. PubMed ID: 34988535
[TBL] [Abstract][Full Text] [Related]
14. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
[TBL] [Abstract][Full Text] [Related]
15. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD).
Guerra F; Palmisano P; Dell'Era G; Ziacchi M; Ammendola E; Bonelli P; Patani F; Cupido C; Devecchi C; Accogli M; Occhetta E; Santangelo L; Biffi M; Boriani G; Capucci A;
Heart Rhythm; 2016 Oct; 13(10):1987-92. PubMed ID: 27291511
[TBL] [Abstract][Full Text] [Related]
16. Ranolazine therapy in drug-refractory ventricular arrhythmias.
Curnis A; Salghetti F; Cerini M; Vizzardi E; Sciatti E; Vassanelli F; Villa C; Inama L; Raweh A; Giacopelli D; Bontempi L
J Cardiovasc Med (Hagerstown); 2017 Jul; 18(7):534-538. PubMed ID: 28368882
[TBL] [Abstract][Full Text] [Related]
17. Dramatic reduction of ventricular tachycardia burden after dronedarone plus mexiletine treatment in a patient refractory to hybrid ablation.
Frutos-López M; Pedrote A; Acosta-Martínez J; Arana-Rueda E
Rev Port Cardiol (Engl Ed); 2020 Mar; 39(3):171-173. PubMed ID: 32336522
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic ventricular fibrillation: clinical, electrophysiologic characteristics and long-term outcomes.
Tsai CF; Chen SA; Tai CT; Chiang CE; Ding YA; Chang MS
Int J Cardiol; 1998 Mar; 64(1):47-55. PubMed ID: 9579816
[TBL] [Abstract][Full Text] [Related]
19. The effect of spironolactone on ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators.
Zarraga IG; Dougherty CM; MacMurdy KS; Raitt MH
Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):739-47. PubMed ID: 22773022
[TBL] [Abstract][Full Text] [Related]
20. Anti-arrhythmic drug therapy in implantable cardioverter-defibrillator recipients.
AlTurki A; Proietti R; Russo V; Dhanjal T; Banerjee P; Essebag V
Pharmacol Res; 2019 May; 143():133-142. PubMed ID: 30914300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
